| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF02931317 |
| P698 | PubMed publication ID | 2566638 |
| P50 | author | Andrew Schally | Q141147 |
| P2093 | author name string | Zalatnai A | |
| P2860 | cites work | Estrogen binding proteins in rat pancreas | Q67443802 |
| Carcinoma of the exocrine pancreas: a sex hormone responsive tumour? | Q69118398 | ||
| Response to D-Trp-6-LH-RH in advanced adenocarcinoma of pancreas | Q69883588 | ||
| Hormonal control of pancreatic cancer growth | Q69898848 | ||
| Androgen receptor in human normal and malignant pancreatic tissue and cell lines | Q70027186 | ||
| Cancer statistics, 1987 | Q70320109 | ||
| The control of human pancreatic adenocarcinoma xenografts in nude mice by hormone therapy | Q70474365 | ||
| Adenocarcinoma of the pancreas--a hormone sensitive tumor? A preliminary report on Nolvadex treatment | Q71033061 | ||
| Carcinogenic effect of N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine, a postulated proximate pancreatic carcinogen in Syrian hamsters | Q28322694 | ||
| Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer | Q34355086 | ||
| Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone | Q34598135 | ||
| Oestrogen receptor proteins in malignant and fetal pancreas | Q34782981 | ||
| Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones. | Q36245969 | ||
| Steroid receptors in exocrine glands: The pancreas and prostate | Q39689560 | ||
| Estrogens and pancreatic cancer: some recent aspects | Q39734843 | ||
| Clinical applications of LHRH and its analogues | Q40090981 | ||
| Antitumor Effects of Analogs of Hypothalamic Hormones in Endocrine-Dependent Cancers | Q40092940 | ||
| Pancreatic cancer in the Syrian hamster induced by N-nitrosobis(2-oxopropyl)-amine: cocarcinogenic effect of epidermal growth factor. | Q41861412 | ||
| Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model | Q42374570 | ||
| Pancreatic carcinogenesis: effect of secretin in the hamster- nitrosamine model | Q44364140 | ||
| Somatostatin: a peptide with unexpected physiologic activities | Q48264375 | ||
| Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines. | Q54428658 | ||
| P433 | issue | 2 | |
| P921 | main subject | pancreatic cancer | Q212961 |
| P304 | page(s) | 149-160 | |
| P577 | publication date | 1989-03-01 | |
| P1433 | published in | International Journal of Pancreatology | Q27711541 |
| P1476 | title | Responsiveness of the hamster pancreatic cancer to treatment with microcapsules of D-Trp-6-LH-RH and somatostatin analog RC-160. Histological evidence of improvement | |
| P478 | volume | 4 |
| Q34394264 | Biology of pancreatic cancer |
| Q53491265 | Effects of orchiectomy, alone or in combination with testosterone, and cyproterone acetate on exocrine pancreatic carcinogenesis in rats and hamsters |
| Q74372164 | Establishment and characterization of a new transplantable pancreatic cancer xenograft (PZX-5) in immunosuppressed mice |
| Q36795691 | Hormones and pancreatic cancer |
| Q35613016 | Pancreatic cancer - a continuing challenge in oncology |
| Q33844684 | Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase |
| Q40623865 | Somatostatin and the treatment of pancreatic cancer |
| Q36038482 | Somatostatin, somatostatin receptors, and pancreatic cancer |
Search more.